Opthea (ASX:OPT) has announced it will discontinue clinical trials involving its sozinibercept in combination with other therapies for treating wet age-related macular degeneration. …
Latest Video
New Stories
-
'Last week's Budget a missed opportunity for fairer policies to support not-for-profits'
April 2, 2025 - - Latest News -
Diabetes Australia calls for election focus on wider access to technologies
April 1, 2025 - - Latest News -
US focused on Australia implementing an IP commitment under bilateral trade agreement
April 1, 2025 - - Latest News -
Ipsen welcomes TGA registration of treatment for primary biliary cholangitis
April 1, 2025 - - Latest News -
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease
April 1, 2025 - - Latest News -
Novo Nordisk forms Aboriginal and Torres Strait Islander Health Advisory Council
April 1, 2025 - - Latest News -
GSK brings Melbourne discovered treatment 'home' to Australian patients
April 1, 2025 - - Latest News